Biomarkers of renal injury
View Patent ↗This invention is related to the field of the prevention and treatment of kidney disease. The treatment of kidney disease may be tailored depending upon the need for, or expectation of, long-term dialysis. For example, prediction of long-term dialysis treatment can be determined by monitoring urine biomarkers related to the development of chronic kidney disease. For example, a normalized time course of approximately fourteen Days measuring hyaluronic acid, death receptor 5, and/or transforming growth factor β1 can be used to establish the risk of recovery versus non-recovery in patient's having suffered an acute kidney injury.
1. A method for predicting dialysis independence after an acute renal injury, comprising:
a) initiating renal replacement therapy in a patient having an acute renal injury, wherein said patient does not have an end stage renal disease;
b) collecting at least two urine samples from said patient within fourteen days of said initiating renal replacement therapy;
c) introducing said at least two urine samples into an assay device that detects a hyaluronic acid value normalized to urinary creatinine content in said urine sample, wherein said hyaluronic acid level decreases between an earlier urine sample hyaluronic acid value and a later urine sample hyaluronic acid level; and
d) calculating therefrom an area under the curve receiver operated characteristic (AUC ROC) determination patient value between said earlier and later urine sample hyaluonic acid levels;
e) correlating said AUC ROC patient value to an AUC ROC predetermined threshold value to determine a probability of recovery versus non-recovery for said patient;
f) predicting a recovery of said patient when said probability of recovery vesus non-recovery correlates said AUC ROC patient value at or above said AUC ROC predetermined threshold value; and
g) removing said patient from said renal replacement therapy under conditions of dialysis independence.
2. The method of claim 1 , wherein said predicted probability of renal recovery versus non-recovery occurs within at least sixty Days from the onset of said acute renal injury.
3. The method of claim 1 , wherein said sample is obtained within one Day from said initiation of renal replacement therapy.
4. The method of claim 1 , wherein said predetermined threshold value comprises a urinary hyaluronic acid threshold value.
5. The method of claim 4 , wherein said urinary hyaluronic acid threshold value is approximately 12 μg/mg of creatinine.
6. The method of claim 4 , wherein said urinary hyaluronic acid threshold value comprises an area under the receiver operating characteristic curve (AUC ROC) value of at least 0.70.
7. The method of claim 1 , wherein said predetermined threshold value comprises a hyaluronic acid threshold value and at least one clinical indicia threshold value.
8. The method of claim 7 , wherein said urinary hyaluronic acid threshold value and said at least one clinical indicia threshold value comprises an area under the receiver operating characteristic curve (AUC ROC) value of at least 0.75.
9. The method of claim 1 , wherein said predetermined threshold value comprises at least one clinical indicia threshold value.
10. The method of claim 1 , wherein said patient value further comprises at least one clinical indicia value is selected from the group consisting of age, SOFA score, Charlson comorbidity index, and APACHE II score.
11. The method of claim 9 , wherein said at least one clinical indicia threshold value comprises an area under the receiver operating characteristic curve (AUC ROC) value of at least 0.71.
12. The method of claim 1 , wherein said patient value further comprises at least two patient clinical indicia values.
13. The method of claim 1 , wherein said predetermined threshold value comprises at least two clinical indicia threshold values that comprises an area under the receiver operating characteristic curve (AUC ROC) value of at least 0.74.
14. The method of claim 12 , wherein said at least two clinical indica values comprise an age value and a Charlson comorbidity index value.